Novonesis (Novozymes) B/ DK0060336014 /
| 2024-05-21 2:55:36 PM | Chg. - | Volume | Bid9:00:02 AM | Ask9:00:02 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 427.05DKK | - | 303 Turnover: 129,460.10 |
-Bid Size: - | -Ask Size: - | 117.6 bill.DKK | 1.42% | 31.75 |
Fundamentals
| FY 2022 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 13.29 DKK | 17.40% |
| EPS Diluted: | - DKK | 17.45% |
| Revenues per Share: | 62.97 DKK | -3.86% |
| Book Value per Share: | 49.64 DKK | -4.19% |
| Cash Flow per Share: | 14.37 DKK | -19.24% |
| Dividend per Share: | 6.00 DKK | 9.09% |
| Total | in mill. | |
| Revenues: | 17,553.00 DKK | 17.40% |
| Net Income: | 3,686.00 DKK | 17.20% |
| Operating Cash Flow: | 4,006.00 DKK | - |
| Cash and Cash Equivalents: | 1,041.00 DKK | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 31.75 | 26.48 |
| P/S Ratio: | 6.70 | 5.59 |
| P/BV ratio: | 8.50 | 7.09 |
| P/CF Ratio: | 29.36 | 24.48 |
| PEG: | 1.82 | 1.52 |
| Earnings Yield: | 3.15% | 3.78% |
| Dividend Yield: | 1.42% | 1.71% |
| Market Capitalization | ||
| Market Capitalization: | 117.6 bill. DKK | 98.09 bill. DKK |
| Free Float Market Cap.: | - DKK | - DKK |
| Market Cap. / Employee: | 17.34 mill. DKK | 14.46 mill. DKK |
| Shares Outstanding: | 278.73 mill. | |
Profitability
| Gross Profit Margin: | 54.56% |
| EBIT Margin: | 25.98% |
| Net Profit Margin: | 21.00% |
| Return on Equity: | 26.64% |
| Return on Assets: | 13.17% |
Financial Strength
| Liquidity I / Cash Ratio: | 14.95% |
| Liquidity II / Quick Ratio: | 64.56% |
| Liquidity III / Current Ratio: | 132.72% |
| Debt / Equity Ratio: | 102.23% |
| Dynam. Debt / Equity Ratio: | 353.12% |
Efficiency
| Employees: | 6,781 |
| Personal Expenses / Employee: | - DKK |
| Revenues / Employee: | 2,588,556.26 DKK |
| Net Income / Employee: | 543,577.64 DKK |
| Total Assets / Employee: | 4,126,677.48 DKK |
| * Fiscal Year End: | 2022-12-31 |
| Accounting Standard: | IFRS |
| Currency: | DKK |
